Navigation Links
Azotobacter vinelandii

Multiporator / Electroporator 2510 Transformation Protocol

Protocol No. 4308 915.503 04/2002

Microorganism Azotobacter vinelandii Cell type Bacteria, gram negative Molecules injected Plasmid DNA Growth medium Nitrogen-free medium Washing solution Ice-cold 10% sterile glycerol Electroporation solution Ice-cold 10% sterile glycerol Outgrowth medium Azotobacter growth (AG) medium Cuvette 1 mm gap width Reference Kornyi, P. et al 1998 Research in Microbiology 149 361-372

Making electrocompetent cells:

  1. Cultivate cells with vigorous shaking at 30 C to an O.D.620 of 0.4-0.5.

  2. Harvest by centrifugation at 5,000 rpm for 10 min at 0 C.

  3. Wash with the original culture volume of ice-cold 10% glycerol.

  4. Repeat this step three times using a half and a quarter of the original volume, and finally 2-4 ml of the glycerol solution (7.0 x 107 cells/ml final cell concentration).

  5. Freeze 40 l aliquots in liquid nitrogen and store at 70
    '"/>


Source:


Page: All 1 2

Related biology technology :

1. Azotobacter vinelandii
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Azotobacter vinelandii

Breaking Biology News(10 mins):Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 2Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 3Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 4Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 5Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 6Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 7Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 8Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 9Leibniz Prize 2010: 10 winners receive honor, prize money and 'idyllic freedom' 10Brooding fishes take up nutrients from their own children 2First-in-class treatment for acute leukemia 2First-in-class treatment for acute leukemia 3Michael J Fox Foundation Commits Up to 245 Million to Help Advance Neurotrophic Factors From Promise to Reality As Parkinsons Treatment 58205 1Michael J Fox Foundation Commits Up to 245 Million to Help Advance Neurotrophic Factors From Promise to Reality As Parkinsons Treatment 58205 2American Heart Association Meeting Report 3A High Sugar Diet Increases Mens Blood Pressure 3B Gout Drug Protective 58200 1American Heart Association Meeting Report 3A High Sugar Diet Increases Mens Blood Pressure 3B Gout Drug Protective 58200 2American Heart Association Meeting Report 3A High Sugar Diet Increases Mens Blood Pressure 3B Gout Drug Protective 58200 3American Heart Association Meeting Report 3A High Sugar Diet Increases Mens Blood Pressure 3B Gout Drug Protective 58200 4American Heart Association Meeting Report 3A High Sugar Diet Increases Mens Blood Pressure 3B Gout Drug Protective 58200 5American Heart Association Meeting Report 3A High Sugar Diet Increases Mens Blood Pressure 3B Gout Drug Protective 58200 6Abbotts XIENCE V 28R 29 Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS 28R 29 Liberte in Investigator Initiated 5042 1Abbotts XIENCE V 28R 29 Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS 28R 29 Liberte in Investigator Initiated 5042 2Abbotts XIENCE V 28R 29 Demonstrates Significantly Lower Rates of MACE and Stent Thrombosis Compared to TAXUS 28R 29 Liberte in Investigator Initiated 5042 3